Welcome to LookChem.com Sign In|Join Free

CAS

  • or
10-Oxa-2,5,8-triazadodecanoic acid, 11,11-dimethyl-6,9-dioxo-4,7-bis(phenylmethyl)-, phenylmethyl ester, (4R,7S)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

334942-04-0

Post Buying Request

334942-04-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 10-Oxa-2,5,8-triazadodecanoic acid, 11,11-dimethyl-6,9-dioxo-4,7-bis(phenylmethyl)-, phenylmethyl ester, (4R,7S)-

    Cas No: 334942-04-0

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier

334942-04-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 334942-04-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,4,9,4 and 2 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 334942-04:
(8*3)+(7*3)+(6*4)+(5*9)+(4*4)+(3*2)+(2*0)+(1*4)=140
140 % 10 = 0
So 334942-04-0 is a valid CAS Registry Number.

334942-04-0Downstream Products

334942-04-0Relevant articles and documents

Insertion of an aspartic acid moiety into cyclic pseudopeptides: Synthesis and biological characterization of potent antagonists for the human tachykinin NK-2 receptor

Fedi, Valentina,Altamura, Maria,Balacco, Giuseppe,Canfarini, Franca,Criscuoli, Marco,Giannotti, Danilo,Giolitti, Alessandro,Giuliani, Sandro,Guidi, Antonio,Harmat, Nicholas J. S.,Nannicini, Rossano,Pasqui, Franco,Patacchini, Riccardo,Perrotta, Enzo,Tramontana, Manuela,Triolo, Antonio,Maggi, Carlo Alberto

, p. 6935 - 6947 (2007/10/03)

A new series of monocyclic pseudopeptide tachykinin NK-2 receptor antagonists has been derived from the lead compound MEN11558. A synthesis for these molecules sharing the same intermediate was designed and performed. The replacement of the succinic moiety with an aspartic acid and the functionalization of its amino group with a wide variety of substituents led to very potent and selective NK-2 antagonists. Best results were obtained through the insertion in position 12 of an amino group with R configuration, linked by a short spacer to a saturated nitrogen heterocycle (morpholine, piperidine, or piperazine). The study led to compounds 54 and 57, endowed with high in vivo potency at very low doses and long duration of action in animal models of bronchoconstriction. In particular 54 and 57 completely inhibited NK-2 agonist induced bronchoconstriction in guinea pig after intratracheal administration at subnanomolar doses (ED50 = 0.27 nmol/kg and 0.15 nmol/kg, respectively).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 334942-04-0